Search & Analyze
Popular Searches
Aurobindo Pharma Ltd.
Healthcare₹1,530.600.94%
24 Jul, 4:01 PM
CMP₹1,530.60
Mkt Cap₹87.68K Cr
P/E25.02
P/B2.31
ROE11.15%
52W High₹1,636.00
52W Low₹1,017.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
25.02
P/B Ratio
2.31
EV/EBITDA
11.65
Price/Sales
2.63
Dividend Yield (%)
0.26
EPS (TTM ₹)
60.91
Book Value (₹)
658.53
ROE (%)
11.15
ROCE (%)
14.39
ROA (%)
7.54
EBITDA Margin (%)
10.36
Net Profit Margin (%)
5.48
Debt/Equity
0.24
Current Ratio
1.85
Interest Coverage
12.08
Asset Turnover
1.38
Working Capital/Sales
5.09
Core EBITDA Growth (%)
12.57
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 247746.2 | 234554.9 | 248553.8 | 290018.7 | 317237.3 |
| Net Sales | 247746.2 | 234554.9 | 248553.8 | 290018.7 | 317237.3 |
| Total Income | 251554.7 | 237780.7 | 251459.7 | 295592.5 | 323455.8 |
| Total Expenditure | 194412.2 | 190709.5 | 211367.4 | 231588.7 | 251409.4 |
| Operating Profit | 57142.5 | 47071.2 | 40092.3 | 64003.8 | 72046.4 |
| Depreciation | 10553.9 | 11265.2 | 12445.8 | 15216.6 | 16494.2 |
| Exceptional Items | 28145.8 | -1279.7 | — | -1918.6 | — |
| Profit Before Tax | 73435.9 | 33727.4 | 26125 | 43799.9 | 50662.9 |
| Tax | 20097.7 | 7256.3 | 6848.5 | 12110.2 | 15827.2 |
| Profit After Tax (PAT) | 53338.2 | 26471.1 | 19276.5 | 31689.7 | 34835.7 |
| EPS (₹) | 91.05 | 45.19 | 32.9 | 54.16 | 59.81 |
| Dividend Payout % | 400 | 900 | 300 | 450 | — |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 585.9 | 585.9 | 585.9 | 585.9 | 580.8 |
| Reserves | 218712.8 | 245173.9 | 267812.6 | 297842.1 | 325952.4 |
| Shareholders Funds | 219298.7 | 245759.8 | 268398.5 | 298428 | 326533.2 |
| Total Debt | 49722.7 | 23727.7 | 48615.2 | 63152.2 | 79416.8 |
| Total Liabilities | 334013.1 | 336331.3 | 392125 | 438588.7 | 484920.1 |
| Total Assets | 334013.1 | 336331.3 | 392125 | 438588.7 | 484920.1 |
| Book Value / Share | 374.2937 | 419.4569 | 458.0961 | 509.3497 | 562.2128 |
| Assets | 334013.1 | 336331.3 | 392125 | 438588.7 | 484920.1 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 33290.5 | 50164.8 | 23867.5 | 24345.2 | 39246.2 |
| Investing Activities | 5986.9 | -32115.6 | -39777.5 | -42559.5 | -18758 |
| Financing Activities | -13649.4 | -29692.7 | 18144.1 | 8004.2 | 1197.8 |
| Net Cash Flow | 25628 | -11643.5 | 2234.1 | -10210.1 | 21686 |
AUROPHARMA
₹1,530.60
+0.94%